To highlight the extensive body of knowledge collected in developing the Global Vaccine Action Plan (GVAP), the journal Vaccine today released a special supplement dedicated in full to the Decade of Vaccines.
As part of the DVI program, a team has been working to develop and advance a model for the impact of dengue vaccine immunization on infection and disease, one that allows the simulation of a wide range of scenarios, including the impact of vector control.

Today marks the first day of vaccinations for Phase I, Part II clinical testing of Sabin's human hookworm vaccine in Brazil.

Pages